Stiff person syndrome masquerading as multiple sclerosis

Joseph J. Sabatino, Scott Newsome

Research output: Contribution to journalArticle

Abstract

Background Stiff person syndrome (SPS) is a rare neuroimmunological disorder presenting with a wide variety of signs and symptoms that mimic neuro-inflammatory diseases, such as multiple sclerosis (MS), thus delaying diagnosis. Methods We performed a retrospective chart review of over 100 patients with SPS who were treated at Johns Hopkins Hospital and identified five patients previously diagnosed with MS. Results Patients were female with a mean age of 53 years old (range 43–64). Mean time to SPS diagnosis was 5.5 years. They presented with typical SPS features (axial/leg spasms, torso rigidity, hyperlordosis, and gait instability) as well as atypical features (hemiparesis, hemisensory dysfunction, fine motor impairment) and were all initially given a diagnosis of MS. In all patients, brain MRI demonstrated non-specific white matter lesions and CSF was negative for intrathecal antibodies in the 4 out of 5 patients who underwent lumbar puncture. SPS diagnosis was supported by elevated anti-glutamic acid decarboxylase (GAD65) antibodies in each patient. Two patients were treated with disease-modifying therapies for MS before being diagnosed with SPS. Following diagnosis with SPS, the patients were treated with varying combinations of immunosuppressants and symptomatic therapies resulting in stabilization or improvement in four of the patients. Conclusion We present five patients with SPS, who were initially thought to have MS, including one patient treated with three different MS therapies due to “disease progression”. These cases demonstrate the need to consider less common neuroimmunological disorders, such as SPS, especially in patients with atypical features for MS.

Original languageEnglish (US)
Pages (from-to)297-299
Number of pages3
JournalJournal of the Neurological Sciences
Volume372
DOIs
StatePublished - Jan 15 2017

Fingerprint

Stiff-Person Syndrome
Multiple Sclerosis
Torso
Glutamate Decarboxylase
Spinal Puncture
Antibodies
Spasm
Paresis
Immunosuppressive Agents
Gait
Signs and Symptoms

Keywords

  • Multiple sclerosis
  • Neuroinflammatory diseases
  • Stiff person syndrome

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Stiff person syndrome masquerading as multiple sclerosis. / Sabatino, Joseph J.; Newsome, Scott.

In: Journal of the Neurological Sciences, Vol. 372, 15.01.2017, p. 297-299.

Research output: Contribution to journalArticle

@article{845820a43e0141418dc4f65d02194f03,
title = "Stiff person syndrome masquerading as multiple sclerosis",
abstract = "Background Stiff person syndrome (SPS) is a rare neuroimmunological disorder presenting with a wide variety of signs and symptoms that mimic neuro-inflammatory diseases, such as multiple sclerosis (MS), thus delaying diagnosis. Methods We performed a retrospective chart review of over 100 patients with SPS who were treated at Johns Hopkins Hospital and identified five patients previously diagnosed with MS. Results Patients were female with a mean age of 53 years old (range 43–64). Mean time to SPS diagnosis was 5.5 years. They presented with typical SPS features (axial/leg spasms, torso rigidity, hyperlordosis, and gait instability) as well as atypical features (hemiparesis, hemisensory dysfunction, fine motor impairment) and were all initially given a diagnosis of MS. In all patients, brain MRI demonstrated non-specific white matter lesions and CSF was negative for intrathecal antibodies in the 4 out of 5 patients who underwent lumbar puncture. SPS diagnosis was supported by elevated anti-glutamic acid decarboxylase (GAD65) antibodies in each patient. Two patients were treated with disease-modifying therapies for MS before being diagnosed with SPS. Following diagnosis with SPS, the patients were treated with varying combinations of immunosuppressants and symptomatic therapies resulting in stabilization or improvement in four of the patients. Conclusion We present five patients with SPS, who were initially thought to have MS, including one patient treated with three different MS therapies due to “disease progression”. These cases demonstrate the need to consider less common neuroimmunological disorders, such as SPS, especially in patients with atypical features for MS.",
keywords = "Multiple sclerosis, Neuroinflammatory diseases, Stiff person syndrome",
author = "Sabatino, {Joseph J.} and Scott Newsome",
year = "2017",
month = "1",
day = "15",
doi = "10.1016/j.jns.2016.11.066",
language = "English (US)",
volume = "372",
pages = "297--299",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Stiff person syndrome masquerading as multiple sclerosis

AU - Sabatino, Joseph J.

AU - Newsome, Scott

PY - 2017/1/15

Y1 - 2017/1/15

N2 - Background Stiff person syndrome (SPS) is a rare neuroimmunological disorder presenting with a wide variety of signs and symptoms that mimic neuro-inflammatory diseases, such as multiple sclerosis (MS), thus delaying diagnosis. Methods We performed a retrospective chart review of over 100 patients with SPS who were treated at Johns Hopkins Hospital and identified five patients previously diagnosed with MS. Results Patients were female with a mean age of 53 years old (range 43–64). Mean time to SPS diagnosis was 5.5 years. They presented with typical SPS features (axial/leg spasms, torso rigidity, hyperlordosis, and gait instability) as well as atypical features (hemiparesis, hemisensory dysfunction, fine motor impairment) and were all initially given a diagnosis of MS. In all patients, brain MRI demonstrated non-specific white matter lesions and CSF was negative for intrathecal antibodies in the 4 out of 5 patients who underwent lumbar puncture. SPS diagnosis was supported by elevated anti-glutamic acid decarboxylase (GAD65) antibodies in each patient. Two patients were treated with disease-modifying therapies for MS before being diagnosed with SPS. Following diagnosis with SPS, the patients were treated with varying combinations of immunosuppressants and symptomatic therapies resulting in stabilization or improvement in four of the patients. Conclusion We present five patients with SPS, who were initially thought to have MS, including one patient treated with three different MS therapies due to “disease progression”. These cases demonstrate the need to consider less common neuroimmunological disorders, such as SPS, especially in patients with atypical features for MS.

AB - Background Stiff person syndrome (SPS) is a rare neuroimmunological disorder presenting with a wide variety of signs and symptoms that mimic neuro-inflammatory diseases, such as multiple sclerosis (MS), thus delaying diagnosis. Methods We performed a retrospective chart review of over 100 patients with SPS who were treated at Johns Hopkins Hospital and identified five patients previously diagnosed with MS. Results Patients were female with a mean age of 53 years old (range 43–64). Mean time to SPS diagnosis was 5.5 years. They presented with typical SPS features (axial/leg spasms, torso rigidity, hyperlordosis, and gait instability) as well as atypical features (hemiparesis, hemisensory dysfunction, fine motor impairment) and were all initially given a diagnosis of MS. In all patients, brain MRI demonstrated non-specific white matter lesions and CSF was negative for intrathecal antibodies in the 4 out of 5 patients who underwent lumbar puncture. SPS diagnosis was supported by elevated anti-glutamic acid decarboxylase (GAD65) antibodies in each patient. Two patients were treated with disease-modifying therapies for MS before being diagnosed with SPS. Following diagnosis with SPS, the patients were treated with varying combinations of immunosuppressants and symptomatic therapies resulting in stabilization or improvement in four of the patients. Conclusion We present five patients with SPS, who were initially thought to have MS, including one patient treated with three different MS therapies due to “disease progression”. These cases demonstrate the need to consider less common neuroimmunological disorders, such as SPS, especially in patients with atypical features for MS.

KW - Multiple sclerosis

KW - Neuroinflammatory diseases

KW - Stiff person syndrome

UR - http://www.scopus.com/inward/record.url?scp=85000936595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85000936595&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2016.11.066

DO - 10.1016/j.jns.2016.11.066

M3 - Article

VL - 372

SP - 297

EP - 299

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

ER -